AbbVie Inc. (ABBV) Stock: Rise as Q3 Revenue Jumps 10.3% and EPS Tops $3.82

TLDR AbbVie stock gains 1.72% as third-quarter revenue climbs 10.3% to $17.4 billion. AbbVie reports adjusted EPS of $3.82 as earnings more than double year over year. Skyrizi and Rinvoq drive immunology revenue growth as Humira sales decline 31.2%. AbbVie raises its 2026 adjusted EPS guidance to a range of 13.95–13.99 per share. AbbVie announces [...]

The post AbbVie Inc. (ABBV) Stock: Rise as Q3 Revenue Jumps 10.3% and EPS Tops $3.82 appeared first on Blockonomi.